Physician stated atrial fibrillation management in light of treatment guidelines: Data from an international, observational prospective survey

Clinical Cardiology

Volumn 33, Issue 3, 2010, Pages 172-178

  Kowey, Peter R ^a   Breithardt, Günter ^b   Camm, John ^c   Crijns, Harry ^d   Dorian, Paul ^e   Le Heuzey, Jean Yves ^f   Pedrazzini, Laurence ^g   Prystowsky, Eric N ^h   Salette, Geneviève ^g   Schwartz, Peter J ⁱ   Torp Pedersen, Christian ^j   Weintraub, William ^k  

^a LANKENAU HOSPITAL   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g SANOFI   (France)

^h ST VINCENT HOSPITAL   (United States)

ⁱ UNIVERSITY OF PAVIA   (Italy)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k Christiana Center for Outcomes Research   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; ARTICLE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART RATE; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CARDIAC GLYCOSIDES; CARDIOTONIC AGENTS; CLINICAL COMPETENCE; FEMALE; FLECAINIDE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART RATE; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROPAFENONE; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGISTRIES; SOTALOL;

EID: 77949699456     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20737     Document Type: Article

References (8)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983-988.
2. Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476-484.
3. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
4. Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359-364.
5. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J. 2006;27:1979-2030.
6. Nieuwlaat R, Capucci A, Camm AJ, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2005;26:2422-2434.
7. Meiltz A, Zimmermann M, Urban P, et al. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace. 2008;10:674-680.
8. Le Heuzey J-Y, Breithardt G, Camm J, et al. The Record AF Study: Design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol. 2009 [Online]: 10 Dec; doi:10.1016/j.amjcard.2009.10.012.